Search results
Study supports more selective use of preventive antibiotics for cataract surgery
Center for Infectious Disease Research and Policy· 3 days agoThe study found limiting preventive antibiotics to complicated cataract surgery was as effective as...
Experiments show H5N1 risk to dairy cows not exclusive to subtype infecting US herds
Center for Infectious Disease Research and Policy· 4 days agoAnimal and Plant Health Inspection Service (APHIS) over the last few days has confirmed 14 more...
Insider Selling: QuidelOrtho Co. (NASDAQ:QDEL) Major Shareholder Sells 127,981 Shares of Stock
ETF DAILY NEWS· 6 days agoQuidelOrtho Co. (NASDAQ:QDEL – Get Free Report) major shareholder Carlyle Group Inc. sold 127,981 shares of the company’s stock in a transaction dated Friday, June 14th. Following the sale, ...
FDA approves new drug to treat autoimmune liver disease: ‘Giant step forward’
Fox News via Yahoo News· 4 days agoThe U.S. Food and Drug Administration has approved the French drugmaker Ipsen’s medication Iqirvo...
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 5 days agoThe Texas Biomedical Research Institute is continuing expansion of a new animal research complex on...
Orpinolide disrupts a leukemic dependency on cholesterol transport by inhibiting OSBP - Nature...
Nature· 4 days agoChemical, genetic and proteomic approaches were used to elucidate the mode of action of orpinolide, a withanolide-inspired OSBP inhibitor, revealing sterol transport as a druggable metabolic dependency in leukemia.
Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May...
Centers for Disease Control and Prevention· 7 days agopH1N1 with Reduced Oseltamivir Inhibition
Gateway - Quartz
Quartz· 7 days agoHumira, a monoclonal antibody used to treat arthritis among other conditions, is the most lucrative drug in history. Since entering the market in 2003, it has made its manufacturer ...
Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval
Investor's Business Daily· 3 days agoThe gene therapy, dubbed Elevidys, already had accelerated approval for children age 4 and 5 with the muscle-wasting disease. Late Thursday, the Food and Drug Administration ...
QuidelOrtho Co. (NASDAQ:QDEL) Major Shareholder Carlyle Group Inc. Sells 99,642 Shares
ETF DAILY NEWS· 6 days agoQuidelOrtho Co. (NASDAQ:QDEL – Get Free Report) major shareholder Carlyle Group Inc. sold 99,642 shares of QuidelOrtho stock in a transaction dated Monday, June 17th. The stock was sold at an ...